FundFollowerFundFollower
Super FundsTop AssetsActivityPortfoliosArticlesAbout

Get the FundFollower newsletter

13F-season insights and notable moves. No spam — unsubscribe anytime.

© 2025 FundFollower. All rights reserved.

Data sourced from public SEC filings.

HomeContact UsSuper FundsTop AssetsAbout

Bridgebio Pharma Inc.

BBIO

4 institutional investors and hedge funds own BBIO, holding 22,556,648 shares worth $1.7B (latest 13F filings).

Advanced Chart

Who owns Bridgebio Pharma Inc. stock?

Institutional holders of BBIO — largest position first.

Super Fund
Position
Shares
Curr. Value
Port. %
Activity
Farallon Capital ManagementEquity
10,743,063
$800,143,332
4.72%
+14.71%
Viking Global InvestorsEquity
9,949,219
$741,017,831
2.11%
-15.99%
SC US (TTGP)Equity
1,860,364
$138,559,911
0.44%
0%
Polen Capital ManagementEquity
4,002
$298,069
0.00%
-91.29%

Ownership Statistics

Total Shares Held: 22,556,648
Total Value Reported: $1,680,019,143
Average Allocation per Portfolio 1.82%
Largest Single Portfolio Allocation: 4.72%
Largest Shareholder: Farallon Capital Management
Change in Total Shares Held (Q on Q): -557,547
Percentage Change in Shares Held (Q on Q): -2.41%
Number of Super Fund Holders: 4
Number of New Holders (Q on Q): 0
Number of Funds with Additions (Q on Q): 1
Number of Funds with Reductions (Q on Q): 2
Number of Funds Fully Divested (Q on Q): 0
Number of Funds with No Change (Q on Q): 1

Ownership Distribution

Loading chart…

Ownership History

Loading chart…

Company Profile

Fundamental Data